Multifunctional Nanocarriers for Efficient Treatment against Hepatocellular Carcinoma with Desmoplasia
Biography
Dr. Yunching Chen has received her Ph.D. degree in Pharmaceutical Sciences at the University of North Carolina at Chapel Hill in May 2010. She completed her doctoral thesis under the supervision of Dr. Leaf Huang and developed various novel nanoparticle formulations to deliver RNA therapeutics and chemotherapy drugs for cancer therapy. She later worked with Drs. Rakesh Jain and Dan Duda as a research fellow of Radiation Oncology at Harvard Medical School and Massachusetts General Hospital. She found the tumor stroma plays an important role on immunosuppression, drug resistance, and cancer cell survival and metastasis (Hepatology, 2014; PNAS, 2014). She joined the faculty of National Tsing Hua University as a tenure-track Assistant Professor in 2013. She rose through the ranks to Associate Professor in 2016. Her work provides a molecular understanding for the development of effective combination therapeutic approaches for the treatment of cancer (Hepatology, 2015; Nature Protocols, 2015; Biomaterials, 2015; Journal of Controlled Release, 2015; Hepatology, 2018). She has published 31 journal papers with nearly 2900 citations and an h-index of 19.